Familial Cancer

, Volume 12, Issue 2, pp 295–300 | Cite as

Surgical treatment of hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome)

  • Miguel A. Rodriguez-Bigas
  • Gabriela Möeslein
Original Article


The surgical management of the Lynch syndrome patient with colorectal cancer needs to be individualized. Because of the increased incidence of synchronous and metachronous colorectal neoplasms, most favor an extended resection at the time of diagnosis of colorectal cancer. Age of diagnosis, stage of the tumor, co-morbidities, surgical expertise, surgical morbidity, and patient wishes should be taken into account when considering a surgical procedure. There are no prospective randomized trials or retrospective trials suggesting that patients undergoing an extended procedure have a survival advantage compared to those undergoing segmental resection. In retrospective studies it has been demonstrated that patients undergoing extended procedures will develop less metachronous colorectal neoplasms and will undergo less subsequent surgical procedures related to colorectal cancer. In females abdominal hysterectomy and bilateral salpingoophorectomy should be considered at the time of surgery for colorectal cancer.


Lynch syndrome Hereditary nonpolyposis colorectal cancer HNPCC Surgery Segmental colectomy Abdominal colectomy Colorectal cancer 


  1. 1.
    Vasen HF, Moslein G, Alonso A et al (2007) Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 44(6):353–362. doi: 10.1136/jmg.2007.048991 PubMedCrossRefGoogle Scholar
  2. 2.
    Bonadona V, Bonaiti B, Olschwang S et al (2011) Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA 305(22):2304–2310. doi: 10.1001/jama.2011.743 PubMedCrossRefGoogle Scholar
  3. 3.
    Baglietto L, Lindor NM, Dowty JG et al (2010) Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst 102(3):193–201. doi: 10.1093/jnci/djp473 PubMedCrossRefGoogle Scholar
  4. 4.
    Fitzgibbons RJ Jr, Lynch HT, Stanislav GV et al (1987) Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II). Ann Surg 206(3):289–295PubMedCrossRefGoogle Scholar
  5. 5.
    Vasen HF, Mecklin JP, Khan PM, Lynch HT (1991) The International collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 34(5):424–425PubMedCrossRefGoogle Scholar
  6. 6.
    Vasen HF, Watson P, Mecklin JP, Lynch HT (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116(6):1453–1456PubMedCrossRefGoogle Scholar
  7. 7.
    Rodriguez-Bigas MA, Boland CR, Hamilton SR et al (1997) A national cancer institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89(23):1758–1762PubMedCrossRefGoogle Scholar
  8. 8.
    Umar A, Boland CR, Terdiman JP et al (2004) Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96(4):261–268PubMedCrossRefGoogle Scholar
  9. 9.
    Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ (1995) Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64(6):430–433PubMedCrossRefGoogle Scholar
  10. 10.
    Box JC, Rodriguez-Bigas MA, Weber TK, Petrelli NJ (1999) Clinical implications of multiple colorectal carcinomas in hereditary nonpolyposis colorectal carcinoma. Dis Colon Rectum 42(6):717–721PubMedCrossRefGoogle Scholar
  11. 11.
    de Vos tot Nederveen Cappel WH, Nagengast FM, Griffioen G, et al. (2002) Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families. Dis Colon Rectum 45(12):1588–1594 DOI  10.1097/01.DCR.0000034502.64985.3F
  12. 12.
    Parry S, Win AK, Parry B et al (2011) Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut 60(7):950–957. doi: 10.1136/gut.2010.228056 PubMedCrossRefGoogle Scholar
  13. 13.
    Syngal S, Weeks JC, Schrag D, Garber JE, Kuntz KM (1998) Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Internal Med 129(10):787–796CrossRefGoogle Scholar
  14. 14.
    Maeda T, Cannom RR, Beart RW Jr, Etzioni DA (2010) Decision model of segmental compared with total abdominal colectomy for colon cancer in hereditary nonpolyposis colorectal cancer. J Clin Oncol Off J Am Soc Clin Oncol 28(7):1175–1180. doi: 10.1200/JCO.2009.25.9812 CrossRefGoogle Scholar
  15. 15.
    de Vos tot Nederveen Cappel WH, Buskens E, van Duijvendijk P, et al. (2003) Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect. Gut 52(12):1752–1755Google Scholar
  16. 16.
    Madden MV, Neale KF, Nicholls RJ et al (1991) Comparison of morbidity and function after colectomy with ileorectal anastomosis or restorative proctocolectomy for familial adenomatous polyposis. Br J Surg 78(7):789–792PubMedCrossRefGoogle Scholar
  17. 17.
    Lee JS, Petrelli NJ, Rodriguez-Bigas MA (2001) Rectal cancer in hereditary nonpolyposis colorectal cancer. Am J Surg 181(3):207–210PubMedCrossRefGoogle Scholar
  18. 18.
    Rodriguez-Bigas MA, Vasen HF, Pekka-Mecklin J et al (1997) Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. International collaborative group on HNPCC. Ann Surg 225(2):202–207PubMedCrossRefGoogle Scholar
  19. 19.
    Baba S (1997) Hereditary nonpolyposis colorectal cancer: an update. Dis Colon Rectum 40(10 Suppl):S86–S95PubMedCrossRefGoogle Scholar
  20. 20.
    Kalady MF, Lipman J, McGannon E, Church JM (2012) Risk of colonic neoplasia after proctectomy for rectal cancer in hereditary nonpolyposis colorectal cancer. Ann Surg 255(6):1121–1125. doi: 10.1097/SLA.0b013e3182565c0b PubMedCrossRefGoogle Scholar
  21. 21.
    Moslein G, Nelson H, Thibodeau S, Dozois RR (1998) Rectal carcinomas in HNPCC. Langenbecks Arch Chir Suppl Kongressbd 115:1467–1469PubMedGoogle Scholar
  22. 22.
    Meagher AP, Farouk R, Dozois RR, Kelly KA, Pemberton JH (1998) J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg 85(6):800–803. doi: 10.1046/j.1365-2168.1998.00689.x PubMedCrossRefGoogle Scholar
  23. 23.
    Soravia C, Klein L, Berk T, O’Connor BI, Cohen Z, McLeod RS (1999) Comparison of ileal pouch-anal anastomosis and ileorectal anastomosis in patients with familial adenomatous polyposis. Dis Colon Rectum 42(8):1028–1033 Discussion 33–34PubMedCrossRefGoogle Scholar
  24. 24.
    Natarajan N, Watson P, Silva-Lopez E, Lynch HT (2010) Comparison of extended colectomy and limited resection in patients with Lynch syndrome. Dis Colon Rectum 53(1):77–82. doi: 10.1007/DCR.0b013e3181c702de PubMedCrossRefGoogle Scholar
  25. 25.
    You YN, Chua HK, Nelson H, Hassan I, Barnes SA, Harrington J (2008) Segmental vs. extended colectomy: measurable differences in morbidity, function, and quality of life. Dis Colon Rectum 51(7):1036–1043. doi: 10.1007/s10350-008-9325-1 PubMedCrossRefGoogle Scholar
  26. 26.
    Haanstra JF, de Vos Tot Nederveen Cappel WH, Gopie JP, et al (2012) Quality of life after surgery for colon cancer in patients with Lynch syndrome: partial versus subtotal colectomy. Dis Colon Rectum 55(6):653–659. doi: 10.1097/DCR.0b013e31824f5392
  27. 27.
    Guillem JG, Wood WC, Moley JF et al (2006) ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. J Clin Oncol Off J Am Soc Clin Oncol 24(28):4642–4660. doi: 10.1200/JCO.2005.04.5260 CrossRefGoogle Scholar
  28. 28.
    Burn J, Gerdes AM, Macrae F et al (2011) Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet 378(9809):2081–2087. doi: 10.1016/S0140-6736(11)61049-0 PubMedCrossRefGoogle Scholar
  29. 29.
    Jass JR, Smyrk TC, Stewart SM, Lane MR, Lanspa SJ, Lynch HT (1994) Pathology of hereditary non-polyposis colorectal cancer. Anticancer Res 14(4B):1631–1634PubMedGoogle Scholar
  30. 30.
    Lanspa SJ, Jenkins JX, Cavalieri RJ et al (1994) Surveillance in Lynch syndrome: how aggressive? Am J Gastroenterol 89(11):1978–1980PubMedGoogle Scholar
  31. 31.
    Hendriks YM, Wagner A, Morreau H et al (2004) Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology 127(1):17–25PubMedCrossRefGoogle Scholar
  32. 32.
    Obermair A, Youlden DR, Young JP et al (2010) Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma. Int J Cancer 127(11):2678–2684. doi: 10.1002/ijc.25501 PubMedCrossRefGoogle Scholar
  33. 33.
    Schmeler KM, Lynch HT, Chen LM et al (2006) Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 354(3):261–269. doi: 10.1056/NEJMoa052627 PubMedCrossRefGoogle Scholar
  34. 34.
    Lindor NM, Petersen GM, Hadley DW et al (2006) Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 296(12):1507–1517. doi: 10.1001/jama.296.12.1507 PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Miguel A. Rodriguez-Bigas
    • 1
  • Gabriela Möeslein
    • 1
    • 2
  1. 1.UT MD Anderson Cancer CenterHoustonUSA
  2. 2.St. Josefs-Hospital Bochum-LindenBochumGermany

Personalised recommendations